COMPANY OVERVIEW

Promethera Biosciences is a global innovator in liver cell-based medicines whose mission is to help patients overcome acute and chronic liver diseases.

---

LOCATION

Mont-Saint-Guibert, , Belgium

Durham, NC, USA

Tokyo, , Japan

Basel, , Switzerland

---

THERAPEUTIC AREAS

Fibrotic DIsease

Liver Disease

Rare Diseases

---

WEBSITE

https://www.promethera.com

---

CAREER WEBSITE

https://www.promethera.com/careers

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Nov 11, 2019

Promethera Biosciences Presents Updated Clinical Results at AASLD 2019 for World’s First Stem Cell Therapy Trial using HepaStem™ in Acute-on-Chronic Liver Failure

Oct 31, 2019

Promethera Biosciences: Announcement Regarding Business Activities in Japan

May 9, 2019

Promethera Biosciences Announces First-Dosing in Phase 2a Clinical Study Evaluating World’s First Liver Stem Cell Therapy in Late-Stage NASH Patients

May 7, 2019

Promethera Biosciences Completes €39.7 Million ($44.4 Million) Series D Financing

Apr 15, 2019

Promethera Biosciences Presents Updated Phase 2a Results for World’s First Stem Cell Clinical Trial in ACLF at The International Liver Congress™/ EASL 2019

For More Press Releases

---